For Immediate Release
Forensic Genomics Announces Partnership with International Symposium on Human Identification (ISHI)
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, February 9, 2022—Forensic Genomics is pleased to announce our new partnership agreement with the International Symposium on Human Identification(ISHI). This yearly symposium began more than 30 years ago and has grown into the world’s largest conference focused on technologies, policies, and innovations in forensic DNA analysis for human identification. Experts and DNA analysts from around the world gather to share the latest scientific advances, announce new product concepts, and debate policy issues. The conference is open to all practitioners and suppliers of DNA analysis for human identification
“ISHI is about facilitating collaboration to advance forensic DNA science. We are excited to partner with Forensic Genomics as the official journal of ISHI to provide attendees with a new way to learn about and apply the latest technologies and groundbreaking research to the vital work they perform.” says Carol Bingham, Symposium Manager.
“Mary Ann Liebert Publishers are thrilled to announce our new partnership between our journal, Forensic Genomics, and Promega’s International Symposium on Human Identification. This partnership will provide educational and promotional synergies between the journal and the symposium, supporting our shared mission of advancing DNA technology to enable human identification” says Bob Vrooman, Director, Business Development for Mary Ann Liebert, Inc., publishers.
ISHI is sponsored by Promega Corporation, a global biotechnology company that provides innovative solutions and technical support to the life sciences industry, including products for DNA-based human identification. The company’s product portfolio supports scientific advances in academic, pharmaceutical, clinical, forensic, and industrial/environmental labs worldwide. Promega is headquartered in Madison, WI, with branches in 16 countries.
About the Journal
Forensic Genomics is a new peer-reviewed journal that addresses how advances in genetic testing and genomic analysis can enable investigators to break through previously impenetrable forensic DNA barriers. Led by Editor-in-Chief David Mittelman, PhD, Founder & Chief Executive Officer, Othram, Inc., the Journal focuses on the use of DNA testing technologies, algorithms, artificial intelligence, and genealogical research methods to support human identification using inference tools and inductive reasoning. Forensic Genomics aims to accelerate the validation and adoption of new methods to support investigations that would be otherwise stalled with traditional testing methods. For complete information, visit the Forensic Genomics website.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 90 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.